Clinical Characteristics and Related Factors of Pediatric Crohn’s Disease with Perianal Disease

Authors

  • Hongding Wang
  • Dongmei Wei
  • Shenglan Ning
  • Jiani Pan
  • Zhongqin Jin

DOI:

https://doi.org/10.53469/jcmp.2024.06(08).46

Keywords:

Clinical Characteristics, Crohn’s Disease, Perianal lesion

Abstract

Objective: Perianal Lesions are among the most serious complications of Crohn disease in pediatric. our objective was to analyze the chinical characteristics of crohn's disease with perianal disease in children. And explore the influencing factors of perianal crohn's disease. Methods: A retrospective analysis was conducted on the children, who were diagnosed with Crohn's disease (CD) from April 2019 to April 2023. According to the American gastroenterological association technical review criteria (2003 edition), they were divided into two groups: the perianal lesion (PD) group (n=38) and non- perianal lesion group(n=41). The two groups were compared in terms of clinical characteristics, laboratory test results, Pediatric Crohn’s Disease Activity Index (PCDAI)scores and treatment. Results: The incidence of crohn's disease with perianal disease was 48.1% (38/79). The mean age of the perianal lesion group was10.78±3.69 years, and 78% were males. Among the perianal lesion group, the most common types are anal fistula and perianal abscess, accounting for 36.8%and44.7%.The level of C-reactive protein(CRP), gender and PCDAI scores in the PD group was significantly higher than that in the non-PD group, and the difference between the groups was statistically significant (P<0.05), whlie other serological indexes was not statistically significant (P>0.05). Conclusion: Male children with CD are more likely to be complicated with perianal lesions. When young children, especially boys, have perforation, fistula and other deep penetrating lesions, crohn's disease screening may be considered. The disease activity index of PD crohn's disease in children showed moderate-severe inflammatory changes. Among the perianal lesion group ,there is a high proportion of children with the use of biological agents.

References

Amil-Dias J, Kolacek S, Turner D, Pærregaard A, Rintala R, Afzal NA, Karolewska-Bochenek K, Bronsky J, Chong S, Fell J, Hojsak I, Hugot JP, Koletzko S, Kumar D, Lazowska-Przeorek I, Lillehei C, Lionetti P, Martin-de-Carpi J, Pakarinen M, Ruemmele FM, Shaoul R, Spray C, Staiano A, Sugarman I, Wilson DC, Winter H, Kolho KL; IBD Working Group of ESPGHAN (IBD Porto Group). Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2017 May;64(5):818-835.

Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002 Apr; 122(4):875-80.

Perianal Crohn Disease in a Large Multicenter Pediatric Collaborative. J Pediatr Gastroenterol Nutr. 2017 May; 64(5):e117-e124.

Brückner A, Werkstetter KJ, de Laffolie J, Wendt C, Prell C, Weidenhausen T, Zimmer KP, Koletzko S; CEDATA-GPGE study group. Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA-GPGE Registry. J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):73-78.

Singer AA, GadEglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn's disease in a population-based cohort. Dis Colon Rectum. 2012 Jul;55(7):773-7.

Adler J, Dong S, Eder SJ, Dombkowski KJ; ImproveCareNow Pediatric IBD Learning Health System.epalli SK, Eder SJ, Adler J. Fistulizing Crohn's Disease Presenting After Surgery on a Perianal Lesion. Pediatrics. 2016 Mar;137(3):e20152878.

Seemann NM, Elkadri A, Walters TD, Langer JC. The role of surgery for children with perianal Crohn's disease. J Pediatr Surg. 2015 Jan;50(1):140-3.

Donnelly M, Ryan OK, Ryan ÉJ, Bass GA, Kelly ME, McNamara D, Whelan M, Neary PC, O'Riordan JM, Kavanagh DO. Comparison of Restorative Proctocolectomy with and Without Defunctioning Loop Ileostomy in Patients with Ulcerative Colitis: A Systematic Review and Meta-analysis. J Crohns Colitis. 2023 Jun 16;17(6):876-895.

Eglinton TW, Roberts R, Pearson J, et al. Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort. Am J Gastroenterol. 2012;107(4):589-596.

Assa A, Amitai M, Greer ML, Castro DA, Kuint RC, Martínez-León M, Herman-Sucharska I, Coppenrath E, Anupindi S, Towbin A, Moote D, Konen O, Pratt LT, Griffiths A, Turner D; ImageKids Study Group. Perianal Pediatric Crohn Disease Is Associated With a Distinct Phenotype and Greater Inflammatory Burden. J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):293-298.

Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population - based Studies. Clin Gastroenterol Hepatol. 2018;16(2):190-197.e11.

Mak WY, Mak OS, Lee CK, et al. Significant Medical and Surgical Morbidity in Perianal Crohn's Disease: Results from a Territory-Wide Study. J Crohns Colitis. 2018;12(12):1392-1398.

Shenoy-Bhangle A, Nimkin K, Goldner D, Bradley WF, Israel EJ, Gee MS. MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults. Pediatr Radiol. 2014 Jan;44(1):23-9.

Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, Laureti S, Sampietro GM, Vucelic B, van der Woude CJ, Barreiro-de Acosta M, Maaser C, Portela F, Vavricka SR, Gomollón F; ECCO. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. J Crohns Colitis. 2017 Feb;11(2):135-149

Crandall W, Hyams J, Kugathasan S, Griffiths A, Zrubek J, Olson A, Liu G, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano RN. Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH. J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):183-90.

Iwańczak BM, Ryżko J, Jankowski P, Sładek M, Wasilewska A, Szczepanik M, Sienkiewicz E, Szaflarska-Popławska A, Więcek S, Kwiecień J, Korczowski B, Maślana J. Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study. Adv Clin Exp Med. 2016 May-Jun;25(3):523-30.

Amil-Dias J, Kolacek S, Turner D, Pærregaard A, Rintala R, Afzal NA, Karolewska-Bochenek K, Bronsky J, Chong S, Fell J, Hojsak I, Hugot JP, Koletzko S, Kumar D, Lazowska-Przeorek I, Lillehei C, Lionetti P, Martin-de-Carpi J, Pakarinen M, Ruemmele FM, Shaoul R, Spray C, Staiano A, Sugarman I, Wilson DC, Winter H, Kolho KL; IBD Working Group of ESPGHAN (IBD Porto Group). Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2017 May;64(5):818-835.

Downloads

Published

2024-08-21

How to Cite

Wang, H., Wei, D., Ning, S., Pan, J., & Jin, Z. (2024). Clinical Characteristics and Related Factors of Pediatric Crohn’s Disease with Perianal Disease. Journal of Contemporary Medical Practice, 6(8), 228–232. https://doi.org/10.53469/jcmp.2024.06(08).46